More than 120 vaccines are being studied against Kovid-19 in the world
In the process of combating the global epidemic, the new type of coronavirus (Kovid-19), especially while vaccination studies for protection are promising, scientists have warned that it will not be possible to quickly terminate the pandemic in the world with only the vaccine.
While studies are being conducted on more than 120 vaccines around the world, it is stated that 10 of these vaccines are about to complete the phase-3 phase. 4 American, 4 Chinese, one Russian and one British origin vaccine from German biontech and American Pfizer common vaccine with a Chinese vaccine (inkatif virus vaccine) phase-3 clinical trial continues in Turkey.
In the preliminary report announced by Pfizer and BioNTech, it was emphasized that the vaccine they developed had a protective effect of 90 percent and no significant side effects were reported. In contrast, domestic vaccine production work is still under way in Turkey.
- "No major side effects have been reported from the vaccines coming to Phase-3 so far"
Ankara University (AU) Faculty of Medicine, Head of Infectious Diseases Department and President of Drug Awareness and Rational Medicine Association. Dr. Ismail Fish, AA correspondent, said Kovid-19 vaccine work is continuing rapidly in the world and Turkey.
Emphasizing that vaccination processes are progressing in an unprecedented and incredible speed all over the world due to the bad results caused by the epidemic and the prediction that it will not stop spontaneously, Balık said, "The process of discovery-development-phase studies, which normally takes at least 4-5 years, is 10 for the Kovid-19 vaccine. -12 months. " said.
Fish stated that according to the report published by the World Health Organization (WHO) on 3 November, more than 120 vaccines have been studied, of which 10 vaccines are about to be completed in phase-3.
"At least 2-3 of these vaccines can be licensed and released until the beginning of the year. 4 of these 10 vaccines ending in phase 3 are American, 4 are Chinese, one is Russian and one is British." Saying, said:
"Vaccines require 6-7 different types, most of which are inactive virus vaccines, and two doses, most of which are administered in 2-4 weeks intervals. In our country, the German BioNTech and American Pfizer partnership vaccine (new generation biotechnological production mRNA vaccine) is currently available. Phase-3 clinical studies of the Chinese vaccine (inactive virus vaccine) continue.
These studies are carried out in 10 centers in different cities, including university hospitals and Ministry of Health training and research hospitals. The BioNTech / Pfizer vaccine was made over 40 thousand doses. No significant adverse effects have been reported from the vaccines coming to Phase-3 from both the world and our country. However, it is seen that they are also very effective against Kovid-19. The preliminary report was announced by Pfizer and BioNTech, and the vaccine had 90 percent protective effect and